Pharmacokinetic and exploratory exposure–response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study
暂无分享,去创建一个
J. Baselga | G. von Minckwitz | D. Fumagalli | C. Twelves | S. Girish | G. Jerusalem | S. Monemi | M. Kågedal | I. Nijem | A. Knott | L. Lindbom | J. Bines | Bei Wang | A. Garg | Whitney P. Kirschbrown | R. McConnell | Christie Freeman | Rachelle Mack | Amit Garg | Ihsan Nijem